| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q2'26 | $2.76 | - | - |
| Q1'26 | $3.02 | $3.43 | +13.6% |
| Q4'25 | $2.51 | $2.68 | +6.8% |
| Q3'25 | $2.11 | $2.80 | +32.6% |
| Q2'25 | $1.96 | $2.13 | +8.6% |
| Q1'25 | $2.19 | $2.60 | +18.6% |
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q2'26 | $19.6B | - | - |
| Q1'26 | $19.8B | $20.6B | +4.2% |
| Q4'25 | $18.3B | $17.9B | -2.3% |
| Q3'25 | - | $18.2B | - |
| Q2'25 | - | $16.8B | - |
| Q1'25 | - | $17.7B | - |
Market Data
MS is currently trading at $203.63, giving Morgan Stanley a market cap of 317.08B and a P/E ratio of 17.5. Today's range spans $202.07–$203.92, with shares opening at $202.85 and moving up $2.60 (1.3%) from the prior close. DailyIQ's technical score sits at 95/100 (BUY) with a news sentiment reading of 56/100.
Over the past year MS has traded between $123.88 and $203.09 - the current price is +64.4% off the 52-week low and +0.3% from the high.
MS is scoring 95/100 technically (BUY) and sits at $203.63 - near 52-week highs in its $123.88–$203.09 annual range. Sentiment at 56/100 is neutral. At 317.08B in Financial Services market cap The current P/E ratio stands at 17.5., this is the tier where earnings revision cycles have the most impact on price: upward revisions in a large-cap company with bullish momentum tend to attract analyst upgrades, which in turn attract new institutional mandates.
Earnings revision cycles in large-cap Financial Services names tend to compound: when technicals confirm a BUY thesis (95/100) and news sentiment (56/100, neutral) supports the narrative, analyst upgrades follow price rather than lead it. At $203.63 (near 52-week highs), MS's position within the $123.88–$203.09 annual range suggests there's room for multiple expansion before the stock encounters meaningful technical resistance.
Most recent articles, ranked by recency (click to expand).
Sentiment gathered from recent headlines